Sawaf Aziz — SEC insider filings

SEC reporting owner CIK 1961289. 22 insider filings on record with FilingPulse; latest filed 2026-11-16.

Transaction summary — filings shown

Covers all 22 filings on record, filed 2023-02-22 to 2026-11-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Theravance Biopharma, Inc. (TBPH)SVP & CHIEF FINANCIAL OFFICER20——22
Vir Biotechnology, Inc. (VIR)EVP, Chief Financial Officer2——2

Insider filings — Sawaf Aziz

FiledFormIssuerReported transactionsSource
2026-11-164Vir Biotechnology, Inc. (VIR)Grant/award (A): 75,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2026-10-063Vir Biotechnology, Inc. (VIR)Holdings only — no transactions reportedEDGAR
2026-09-244Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 204,966 · Disposition to issuer (D): 108,436 · Disposition to issuer (D): 23,439EDGAR
2026-08-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 8,112 @ $16.95EDGAR
2026-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 8,670 @ $16.55EDGAR
2026-04-034Theravance Biopharma, Inc. (TBPH)Grant/award (A): 37,500 @ $0EDGAR
2026-02-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 20,672 @ $19.66EDGAR
2025-11-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 18,627 @ $17.90EDGAR
2025-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,368 @ $13.39EDGAR
2025-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 9,348 @ $9.45EDGAR
2025-03-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 75,000 @ $0EDGAR
2025-02-244Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 13,751 @ $9.66EDGAR
2024-11-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 8,477 @ $9.97EDGAR
2024-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 8,635 @ $8.22EDGAR
2024-05-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 8,635 @ $9.10EDGAR
2024-04-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 100,000 @ $0EDGAR
2024-02-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 17,036 @ $8.92EDGAR
2023-11-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 6,187 @ $10.37EDGAR
2023-08-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 7,114 @ $9.70EDGAR
2023-05-234Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 8,744 @ $11.21EDGAR
2023-03-034Theravance Biopharma, Inc. (TBPH)Grant/award (A): 80,000 @ $0EDGAR
2023-02-224Theravance Biopharma, Inc. (TBPH)Tax withholding (F): 6,783 @ $10.44EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1961289 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs